1. Home
  2. Healthcare
  3. Sarcoidosis Pipeline Analysis 2018

Sarcoidosis Pipeline Analysis 2019 (H1)

  • Published : Mar 2020
  • Report Code : KSI061611478
  • Pages : 114

Offered with this report

Market Data

Market Data and Estimates in Excel

2 Months of Post Sale Analyst Support

2 Months of Post Sale Analyst Support

Requirement Specific Customization

Requirement Specific Customization

Sarcoidosis Analysis report covers 6 drugs currently in different phases of development. Sarcoidosis is an inflammatory disease characterised by growth and inflammation of granulomas in various organs, predominantly in the lungs and intrathoracic lymph nodes. The exact cause of sarcoidosis is not known. Symptoms of the sarcoidosis differ as per the organ affected by the disease. However, general symptoms include fatigue, chills and fever, swollen lymph nodes and weight loss. Tests for the diagnosis of the disease include chest x-ray, pulmonary function test, blood test, biopsy, bronchoalveolar lavage, gallium scanning, kveim test and slit-lamp examination.

The report provides Sarcoidosis treatment drugs by company, phases of development including products in early discovery stage and NDA filing, molecule type, route of administration and region. The report will help to evaluate the collaboration, in-licensing and out-licensing opportunities, formulating business development strategies and tracking the activities of the key market players. Epidemiology, major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Various databases (for patents and Clinical Trials), studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.

Major industry players profiled as part of the report are Araim Pharmaceuticals, Inc., Novartis, OncoArendi Therapeutics, Reata Pharmaceuticals, Inc. and Relief Therapeutics among others.

Scope:

  • By Company
  • By Phase
  • By Molecule Type
  • By Region
  • By Route of Administration

* There may be changes in final report as per data availability. 

1. Introduction
1.1. Research Methodology
1.2. Research Scope
1.2.1. Analysis by Company
1.2.2. Analysis by Phase
1.2.3. By Molecule Type
1.2.4. By region
2. Disease Overview
2.1.1. Introduction
2.1.2. Classification
2.1.3. Symptoms
2.1.4. Causes
2.1.5. Diagnoses
2.1.6. Treatment
2.1.7. Epidemiology
3. Executive Summary
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities
5. Pipeline Analysis/Outlook
5.1. Analysis by Company
5.2. Analysis by Phase
5.2.1. Phase of Development
5.2.1.1. Introduction
5.2.1.1.1. Drug Profiling
• Drug Name
• Generic Name
• Synonyms
• Company
• Collaborator
• Route of administration
• Target 
• Mechanism of Action
• Technology
• Molecule type
• CAS Number
• Weight
• Chemical Formula
• IUPAC name
• ATC code
5.2.1.1.2. Strategic Developments
5.2.1.1.3. Clinical trials
5.2.1.1.4. Clinical trial results
5.2.1.1.5. Patents
5.2.1.1.6. Technology
5.2.2. Comparative Analysis for Trials by Phase (Pie, Bar graph)
5.3. By Molecule type
5.4. Analysis by Region
6. Company Profiles
6.1. Araim Pharmaceuticals, Inc.
6.1.1. Introduction
6.1.2. Financials
6.1.3. Products and Services
6.1.4. SWOT
6.1.5. Recent Developments
6.2. Novartis
6.2.1. Introduction
6.2.2. Financials
6.2.3. Products and Services
6.2.4. SWOT
6.2.5. Recent Developments
6.3. OncoArendi Therapeutics
6.3.1. Introduction
6.3.2. Financials
6.3.3. Products and Services
6.3.4. SWOT
6.3.5. Recent Developments
6.4. Reata Pharmaceuticals, Inc.
6.4.1. Introduction
6.4.2. Financials
6.4.3. Products and Services
6.4.4. SWOT
6.4.5. Recent Developments
6.5. Relief Therapeutics
6.5.1. Introduction
6.5.2. Financials
6.5.3. Products and Services
6.5.4. SWOT
6.5.5. Recent Developments
6.6. Auven Therapeutics
6.6.1. Introduction
6.6.2. Financials
6.6.3. Products and Services
6.6.4. SWOT
6.6.5. Recent Developments
6.7. aTyr Pharma, Inc.
6.7.1. Introduction
6.7.2. Financials
6.7.3. Products and Services
6.7.4. SWOT
6.7.5. Recent Developments
6.8. Altavant Sciences, Inc.
6.8.1. Introduction
6.8.2. Financials
6.8.3. Products and Services
6.8.4. SWOT
6.8.5. Recent Developments
List of Tables
List of Figures
* There may be changes in final report as per data availability. 
 

Araim Pharmaceuticals, Inc.

Novartis

OncoArendi Therapeutics

Reata Pharmaceuticals, Inc.

Relief Therapeutics

Auven Therapeutics

aTyr Pharma, Inc.

Altavant Sciences, Inc.

Related Reports

Report Name Published Month Get Sample PDF
Connected Agriculture Market Size & Share: Report, 2021-2026 Sep 2021
Pyrometer Market Size, Share & Trends: Industry Report, 2021-2026 Jun 2021
Radiotherapy Market Size & Share: Industry Report, 2021-2026 Jul 2021
Data Center Colocation Market Size & Share: Report, 2023 - 2028 Jun 2023
Industrial Enzymes Market Share & Trends: Report, 2024-2029 Mar 2024

License Type

$1750
$2350
$3000
$3600
$6000

Explore custom options available with this study

  • Customize this report
  • Buy sections of the study
  • Buy country specific report